Pfizer Predicts Record Profits From COVID Products, Says Chances ‘Very High’ FDA Will Authorize Vaccine for Babies and Toddlers • Children's Health Defense

Pfizer announced Tuesday projected combined sales of its COVID vaccine and antiviral drug Paxlovid should top $54 billion in 2022, constituting more than 50% of the company’s expected revenues of about $100 billion.

Pfizer Predicts Record Profits From COVID Products, Says Chances ‘Very High’ FDA Will Authorize Vaccine for Babies and Toddlers

Pfizer announced Tuesday projected combined sales of its COVID vaccine and antiviral drug Paxlovid should top $54 billion in 2022, but the company’s stock dropped sharply today.